AMI Asset Management Corp Sells 1,882 Shares of Synopsys, Inc. $SNPS

AMI Asset Management Corp trimmed its holdings in Synopsys, Inc. (NASDAQ:SNPSFree Report) by 3.2% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 56,230 shares of the semiconductor company’s stock after selling 1,882 shares during the quarter. Synopsys comprises about 1.5% of AMI Asset Management Corp’s holdings, making the stock its 28th biggest holding. AMI Asset Management Corp’s holdings in Synopsys were worth $27,743,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. Symphony Financial Ltd. Co. raised its holdings in shares of Synopsys by 4,780.9% during the 2nd quarter. Symphony Financial Ltd. Co. now owns 40,219 shares of the semiconductor company’s stock worth $20,638,000 after buying an additional 39,395 shares in the last quarter. HBW Advisory Services LLC grew its position in Synopsys by 494.9% in the second quarter. HBW Advisory Services LLC now owns 3,611 shares of the semiconductor company’s stock valued at $1,851,000 after acquiring an additional 3,004 shares during the last quarter. Bank of New York Mellon Corp raised its stake in Synopsys by 0.4% during the second quarter. Bank of New York Mellon Corp now owns 1,347,887 shares of the semiconductor company’s stock worth $691,035,000 after acquiring an additional 4,815 shares in the last quarter. Westbourne Investments Inc. bought a new position in shares of Synopsys in the second quarter worth about $1,505,000. Finally, Mirae Asset Global Investments Co. Ltd. boosted its stake in shares of Synopsys by 1.7% in the 2nd quarter. Mirae Asset Global Investments Co. Ltd. now owns 178,786 shares of the semiconductor company’s stock valued at $91,660,000 after purchasing an additional 2,991 shares in the last quarter. Institutional investors own 85.47% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the stock. Needham & Company LLC upped their price objective on shares of Synopsys from $550.00 to $580.00 and gave the stock a “buy” rating in a research report on Thursday, December 11th. Weiss Ratings reiterated a “hold (c)” rating on shares of Synopsys in a report on Wednesday, October 8th. Stifel Nicolaus dropped their price target on Synopsys from $650.00 to $550.00 and set a “buy” rating for the company in a research note on Wednesday, September 10th. Mizuho reduced their price objective on Synopsys from $700.00 to $600.00 and set an “outperform” rating on the stock in a research report on Thursday, September 11th. Finally, BNP Paribas began coverage on Synopsys in a report on Thursday, October 2nd. They issued an “underperform” rating and a $425.00 target price for the company. Eleven research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $562.13.

View Our Latest Stock Report on SNPS

Insider Activity

In related news, CFO Shelagh Glaser sold 3,657 shares of the company’s stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the sale, the chief financial officer owned 17,842 shares in the company, valued at $8,221,058.34. This represents a 17.01% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.62% of the stock is owned by corporate insiders.

Synopsys Trading Up 0.0%

NASDAQ:SNPS opened at $475.50 on Friday. Synopsys, Inc. has a 52 week low of $365.74 and a 52 week high of $651.73. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.52 and a current ratio of 1.62. The firm’s fifty day moving average is $436.99 and its 200-day moving average is $503.73. The firm has a market cap of $90.97 billion, a P/E ratio of 59.51, a P/E/G ratio of 3.96 and a beta of 1.16.

Synopsys (NASDAQ:SNPSGet Free Report) last released its earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.79 by $0.11. The business had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.25 billion. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. Synopsys’s revenue for the quarter was up 37.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $3.40 earnings per share. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. Equities analysts expect that Synopsys, Inc. will post 10.64 earnings per share for the current year.

Synopsys Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Read More

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.